Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $41.7200 (-1.14%) ($41.7200 - $41.7200) on Mon. Apr. 18, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.05% (three month average) | RSI | 70 | Latest Price | $41.7200(-1.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.1% a day on average for past five trading days. | Weekly Trend | HALO advances 1.7% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(49%) IWM(44%) IWO(44%) IWN(42%) IWC(41%) | Factors Impacting HALO price | HALO will decline at least -1.025% in a week (0% probabilities). VIXM(-23%) UUP(-10%) VXX(-8%) TBT(-4%) GLD(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.025% (StdDev 2.05%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $41.69(0.07%) | 10 Day Moving Average | $41.77(-0.12%) | 20 Day Moving Average | $40.49(3.04%) | To recent high | -1.5% | To recent low | 30.5% | Market Cap | $5.702b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |